Top Expert Pediatric Gastroenterology and Nutrition Dr. Carlos Lifschitz joins ELSE’s Scientific Advisory Board

Dr. Carlos Lifschitz

Dr. Carlos Lifschitz

Dr. Carlos Lifschitz

VANCOUVER, British Columbia, Feb. 10, 2022 (GLOBE NEWSWIRE) — ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) (“Else” or the “Company”) the Plant-Based child, toddler and youngsters diet company, is happy to announce that Dr. Carlos Lifschitz has joined Else Nutrition’s Scientific Advisory Board.

Dr. Lifschitz is the Associate Physician on the Italian Hospital, Buenos Aires, Argentina and former Associate Professor at Baylor College of Medicine, Houston, Texas, USA. He is a member of the European and Latin American Societies for Pediatric gastroenterology, Hepatology and Nutrition and of the International Editorial Board of the journal Pediatric Gastroenterology, Hepatology and Nutrition (PGHN). Dr. Lifschitz is an acclaimed writer of 95 peer reviewed publications and a couple of books.

“We are very happy that Dr. Lifschitz has joined our Advisory Board. He is an esteemed skilled within the area of Pediatric Gastroenterology and Nutrition and his huge expertise will assist serve us in a profound approach alongside our pathway to offer actual, Clean Label, Plant-Based diet choices to wanting households worldwide,” mentioned Hamutal Yitzhak, CEO of Else Nutrition.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based meals and diet firm targeted on growing progressive, clear and plant-based meals and diet merchandise for infants, toddlers, kids, and adults. Its revolutionary, plant-based, non-soy, components is a clean-ingredient different to dairy-based components. Else Nutrition (previously INDI) gained the “2017 Best Health and Diet Solutions” award on the Global Food Innovation Summit in Milan. Else Plant-Based Complete Nutrition for Toddlers was lately ranked because the #1 Top vendor within the child and toddler components class on Amazon. The Company lately obtained the World Plant-Based Award for “Best dairy different product” in New York at World Plant-Based Expo in late 2021. The holding firm, Else Nutrition Holdings Inc., is a publicly traded firm, listed as TSX Venture Exchange below the buying and selling image BABY and is quoted on the US OTC Markets QX board below the buying and selling image BABYF and on the Frankfurt Exchange below the image 0YL. Else’s Executives consists of leaders hailing from main toddler diet firms. Many of Else advisory board members had previous government roles in firms corresponding to Mead Johnson, Abbott Nutrition, Plum Organics and main toddler diet Societies, and a few of them at present serve in numerous roles in main medical facilities and tutorial institutes corresponding to Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.

For extra data, go to: or @elsenutrition on Facebook and Instagram.

Investor Relations Contact:
Lytham Partners, LLC
Mr. Ben Shamsian
New York | Phoenix
E: [email protected]
P: 646-829-9701
TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation companies supplier (as that time period is outlined within the insurance policies of the TSX Venture Exchange) accepts accountability for the adequacy or accuracy of this launch.

Caution Regarding Forward-Looking Statements

This press launch incorporates statements that might represent “forward-looking statements” inside the which means of relevant securities laws. Forward-looking statements are sometimes recognized by phrases corresponding to “will” or related expressions. Forward-looking statements on this press launch embody statements with respect to the anticipated dates for submitting the Company’s monetary disclosure paperwork. Such forward-looking statements mirror present estimates, beliefs and assumptions, that are based mostly on administration’s notion of present situations and anticipated future developments, in addition to different components administration believes are acceptable within the circumstances. No assurance may be provided that the foregoing will show to be right. Forward-looking statements made on this press launch assume, amongst others, the expectation that there shall be no interruptions or provide chain failures because of COVID 19 and that the manufacturing, dealer and provide logistic settlement with the Company don’t terminate. Actual outcomes might differ from the estimates, beliefs and assumptions expressed or implied within the forward-looking statements. Readers are cautioned to not place undue reliance on any forward-looking statements, which mirror administration’s expectations solely as of the date of this press launch. The Company disclaims any obligation to replace or revise any forward-looking statements, whether or not because of new data, future occasions or in any other case, besides as required by regulation.

A photograph accompanying this announcement is accessible at

Recommended For You

About the Author: Adrian

Leave a Reply